Report Detail
Global Drug Delivery in Cancer Market Size, Status and Forecast 2019-2025
- RnM3325631 |
- 17 April, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Other
In 2018, the global Drug Delivery in Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Delivery in Cancer development in United States, Europe and China.
The key players covered in this study
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Market segment by Type, the product can be split into
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market segment by Application, split into
Hospitals & Clinic
Cancer Treatment Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players.
To present the Drug Delivery in Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Drug Delivery in Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Liposomes
- 1.4.3 PEGylated Proteins & Polypeptides
- 1.4.4 Polymer Nanoparticle
- 1.4.5 Protein–drug Conjugates
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Drug Delivery in Cancer Market Share by Application (2014-2025)
- 1.5.2 Hospitals & Clinic
- 1.5.3 Cancer Treatment Centers
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Drug Delivery in Cancer Market Size
- 2.2 Drug Delivery in Cancer Growth Trends by Regions
- 2.2.1 Drug Delivery in Cancer Market Size by Regions (2014-2025)
- 2.2.2 Drug Delivery in Cancer Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Drug Delivery in Cancer Market Size by Manufacturers
- 3.1.1 Global Drug Delivery in Cancer Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
- 3.2 Drug Delivery in Cancer Key Players Head office and Area Served
- 3.3 Key Players Drug Delivery in Cancer Product/Solution/Service
- 3.4 Date of Enter into Drug Delivery in Cancer Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Drug Delivery in Cancer Market Size by Type (2014-2019)
- 4.2 Global Drug Delivery in Cancer Market Size by Application (2014-2019)
5 United States
- 5.1 United States Drug Delivery in Cancer Market Size (2014-2019)
- 5.2 Drug Delivery in Cancer Key Players in United States
- 5.3 United States Drug Delivery in Cancer Market Size by Type
- 5.4 United States Drug Delivery in Cancer Market Size by Application
6 Europe
- 6.1 Europe Drug Delivery in Cancer Market Size (2014-2019)
- 6.2 Drug Delivery in Cancer Key Players in Europe
- 6.3 Europe Drug Delivery in Cancer Market Size by Type
- 6.4 Europe Drug Delivery in Cancer Market Size by Application
7 China
- 7.1 China Drug Delivery in Cancer Market Size (2014-2019)
- 7.2 Drug Delivery in Cancer Key Players in China
- 7.3 China Drug Delivery in Cancer Market Size by Type
- 7.4 China Drug Delivery in Cancer Market Size by Application
8 Japan
- 8.1 Japan Drug Delivery in Cancer Market Size (2014-2019)
- 8.2 Drug Delivery in Cancer Key Players in Japan
- 8.3 Japan Drug Delivery in Cancer Market Size by Type
- 8.4 Japan Drug Delivery in Cancer Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Drug Delivery in Cancer Market Size (2014-2019)
- 9.2 Drug Delivery in Cancer Key Players in Southeast Asia
- 9.3 Southeast Asia Drug Delivery in Cancer Market Size by Type
- 9.4 Southeast Asia Drug Delivery in Cancer Market Size by Application
10 India
- 10.1 India Drug Delivery in Cancer Market Size (2014-2019)
- 10.2 Drug Delivery in Cancer Key Players in India
- 10.3 India Drug Delivery in Cancer Market Size by Type
- 10.4 India Drug Delivery in Cancer Market Size by Application
11 Central & South America
- 11.1 Central & South America Drug Delivery in Cancer Market Size (2014-2019)
- 11.2 Drug Delivery in Cancer Key Players in Central & South America
- 11.3 Central & South America Drug Delivery in Cancer Market Size by Type
- 11.4 Central & South America Drug Delivery in Cancer Market Size by Application
12 International Players Profiles
- 12.1 Amgen
- 12.1.1 Amgen Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Drug Delivery in Cancer Introduction
- 12.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.1.5 Amgen Recent Development
- 12.2 Teva
- 12.2.1 Teva Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Drug Delivery in Cancer Introduction
- 12.2.4 Teva Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.2.5 Teva Recent Development
- 12.3 UCB (Union Chimique Belge)
- 12.3.1 UCB (Union Chimique Belge) Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Drug Delivery in Cancer Introduction
- 12.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.3.5 UCB (Union Chimique Belge) Recent Development
- 12.4 Roche
- 12.4.1 Roche Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Drug Delivery in Cancer Introduction
- 12.4.4 Roche Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.4.5 Roche Recent Development
- 12.5 Celgene
- 12.5.1 Celgene Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Drug Delivery in Cancer Introduction
- 12.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.5.5 Celgene Recent Development
- 12.6 Sanofi
- 12.6.1 Sanofi Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Drug Delivery in Cancer Introduction
- 12.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.6.5 Sanofi Recent Development
- 12.7 Merck
- 12.7.1 Merck Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Drug Delivery in Cancer Introduction
- 12.7.4 Merck Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.7.5 Merck Recent Development
- 12.8 Johnson & Johnson
- 12.8.1 Johnson & Johnson Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Drug Delivery in Cancer Introduction
- 12.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.8.5 Johnson & Johnson Recent Development
- 12.9 Takeda
- 12.9.1 Takeda Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Drug Delivery in Cancer Introduction
- 12.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.9.5 Takeda Recent Development
- 12.10 Gilead Sciences
- 12.10.1 Gilead Sciences Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Drug Delivery in Cancer Introduction
- 12.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2014-2019)
- 12.10.5 Gilead Sciences Recent Development
- 12.11 Pfizer
- 12.12 Dr Reddy
- 12.13 Samyang Biopharmaceuticals
- 12.14 Tolmar
- 12.15 Astellas
- 12.16 AMAG Pharmaceuticals
- 12.17 AstraZeneca
- 12.18 AbbVie
- 12.19 Novartis
- 12.20 Aspen
- 12.21 Shire (Baxalta)
- 12.22 Breckenridge Pharmaceuticals
- 12.23 Galen Pharmaceuticals
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Drug Delivery in Cancer Market Size, Status and Forecast 2019-2025. Industry analysis & Market Report on Drug Delivery in Cancer Market Size, Status and Forecast 2019-2025 is a syndicated market report, published as Global Drug Delivery in Cancer Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Drug Delivery in Cancer Market Size, Status and Forecast 2019-2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
